Global Colorectal Cancer Diagnostics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Colorectal Cancer Diagnostics Revenue
• 1.4 Market by Type
  • 1.4.1 Global Colorectal Cancer Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 FOB Tests
  • 1.4.3 CTC Tests
  • 1.4.4 CEA Tests
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global Colorectal Cancer Diagnostics Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Specialty Clinics
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Colorectal Cancer Diagnostics Market Perspective (2015-2026)
• 2.2 Global Colorectal Cancer Diagnostics Growth Trends by Regions
  • 2.2.1 Colorectal Cancer Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Colorectal Cancer Diagnostics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Colorectal Cancer Diagnostics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Colorectal Cancer Diagnostics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Colorectal Cancer Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Colorectal Cancer Diagnostics Players by Market Size
  • 3.1.1 Global Top Colorectal Cancer Diagnostics Players by Revenue (2015-2020)
  • 3.1.2 Global Colorectal Cancer Diagnostics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Colorectal Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Colorectal Cancer Diagnostics Market Concentration Ratio
  • 3.2.1 Global Colorectal Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Diagnostics Revenue in 2019
• 3.3 Colorectal Cancer Diagnostics Key Players Head office and Area Served
• 3.4 Key Players Colorectal Cancer Diagnostics Product Solution and Service
• 3.5 Date of Enter into Colorectal Cancer Diagnostics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Colorectal Cancer Diagnostics Historic Market Size by Type (2015-2020)
• 4.2 Global Colorectal Cancer Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Colorectal Cancer Diagnostics Market Size by Application (2015-2020)
• 5.2 Global Colorectal Cancer Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Colorectal Cancer Diagnostics Market Size (2015-2020)
• 6.2 Colorectal Cancer Diagnostics Key Players in North America (2019-2020)
• 6.3 North America Colorectal Cancer Diagnostics Market Size by Type (2015-2020)
• 6.4 North America Colorectal Cancer Diagnostics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Colorectal Cancer Diagnostics Market Size (2015-2020)
• 7.2 Colorectal Cancer Diagnostics Key Players in Europe (2019-2020)
• 7.3 Europe Colorectal Cancer Diagnostics Market Size by Type (2015-2020)
• 7.4 Europe Colorectal Cancer Diagnostics Market Size by Application (2015-2020)

8 China

• 8.1 China Colorectal Cancer Diagnostics Market Size (2015-2020)
• 8.2 Colorectal Cancer Diagnostics Key Players in China (2019-2020)
• 8.3 China Colorectal Cancer Diagnostics Market Size by Type (2015-2020)
• 8.4 China Colorectal Cancer Diagnostics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Colorectal Cancer Diagnostics Market Size (2015-2020)
• 9.2 Colorectal Cancer Diagnostics Key Players in Japan (2019-2020)
• 9.3 Japan Colorectal Cancer Diagnostics Market Size by Type (2015-2020)
• 9.4 Japan Colorectal Cancer Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Colorectal Cancer Diagnostics Market Size (2015-2020)
• 10.2 Colorectal Cancer Diagnostics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Colorectal Cancer Diagnostics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Colorectal Cancer Diagnostics Market Size by Application (2015-2020)

11 India

• 11.1 India Colorectal Cancer Diagnostics Market Size (2015-2020)
• 11.2 Colorectal Cancer Diagnostics Key Players in India (2019-2020)
• 11.3 India Colorectal Cancer Diagnostics Market Size by Type (2015-2020)
• 11.4 India Colorectal Cancer Diagnostics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Colorectal Cancer Diagnostics Market Size (2015-2020)
• 12.2 Colorectal Cancer Diagnostics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Colorectal Cancer Diagnostics Market Size by Type (2015-2020)
• 12.4 Central & South America Colorectal Cancer Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Biocept
  • 13.1.1 Biocept Company Details
  • 13.1.2 Biocept Business Overview
  • 13.1.3 Biocept Colorectal Cancer Diagnostics Introduction
  • 13.1.4 Biocept Revenue in Colorectal Cancer Diagnostics Business (2015-2020))
  • 13.1.5 Biocept Recent Development
• 13.2 Cancer Genetics
  • 13.2.1 Cancer Genetics Company Details
  • 13.2.2 Cancer Genetics Business Overview
  • 13.2.3 Cancer Genetics Colorectal Cancer Diagnostics Introduction
  • 13.2.4 Cancer Genetics Revenue in Colorectal Cancer Diagnostics Business (2015-2020)
  • 13.2.5 Cancer Genetics Recent Development
• 13.3 Foundation Medicine
  • 13.3.1 Foundation Medicine Company Details
  • 13.3.2 Foundation Medicine Business Overview
  • 13.3.3 Foundation Medicine Colorectal Cancer Diagnostics Introduction
  • 13.3.4 Foundation Medicine Revenue in Colorectal Cancer Diagnostics Business (2015-2020)
  • 13.3.5 Foundation Medicine Recent Development
• 13.4 Sysmex Corporation
  • 13.4.1 Sysmex Corporation Company Details
  • 13.4.2 Sysmex Corporation Business Overview
  • 13.4.3 Sysmex Corporation Colorectal Cancer Diagnostics Introduction
  • 13.4.4 Sysmex Corporation Revenue in Colorectal Cancer Diagnostics Business (2015-2020)
  • 13.4.5 Sysmex Corporation Recent Development
• 13.5 Danaher Corporation
  • 13.5.1 Danaher Corporation Company Details
  • 13.5.2 Danaher Corporation Business Overview
  • 13.5.3 Danaher Corporation Colorectal Cancer Diagnostics Introduction
  • 13.5.4 Danaher Corporation Revenue in Colorectal Cancer Diagnostics Business (2015-2020)
  • 13.5.5 Danaher Corporation Recent Development
• 13.6 Epigenomics
  • 13.6.1 Epigenomics Company Details
  • 13.6.2 Epigenomics Business Overview
  • 13.6.3 Epigenomics Colorectal Cancer Diagnostics Introduction
  • 13.6.4 Epigenomics Revenue in Colorectal Cancer Diagnostics Business (2015-2020)
  • 13.6.5 Epigenomics Recent Development
• 13.7 Illumina
  • 13.7.1 Illumina Company Details
  • 13.7.2 Illumina Business Overview
  • 13.7.3 Illumina Colorectal Cancer Diagnostics Introduction
  • 13.7.4 Illumina Revenue in Colorectal Cancer Diagnostics Business (2015-2020)
  • 13.7.5 Illumina Recent Development
• 13.8 Rosetta Genomics
  • 13.8.1 Rosetta Genomics Company Details
  • 13.8.2 Rosetta Genomics Business Overview
  • 13.8.3 Rosetta Genomics Colorectal Cancer Diagnostics Introduction
  • 13.8.4 Rosetta Genomics Revenue in Colorectal Cancer Diagnostics Business (2015-2020)
  • 13.8.5 Rosetta Genomics Recent Development
• 13.9 Exact Science Corporation
  • 13.9.1 Exact Science Corporation Company Details
  • 13.9.2 Exact Science Corporation Business Overview
  • 13.9.3 Exact Science Corporation Colorectal Cancer Diagnostics Introduction
  • 13.9.4 Exact Science Corporation Revenue in Colorectal Cancer Diagnostics Business (2015-2020)
  • 13.9.5 Exact Science Corporation Recent Development
• 13.10 Pathway Genomics Corporation
  • 13.10.1 Pathway Genomics Corporation Company Details
  • 13.10.2 Pathway Genomics Corporation Business Overview
  • 13.10.3 Pathway Genomics Corporation Colorectal Cancer Diagnostics Introduction
  • 13.10.4 Pathway Genomics Corporation Revenue in Colorectal Cancer Diagnostics Business (2015-2020)
  • 13.10.5 Pathway Genomics Corporation Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer